Fortress Biotech (FBIO) Competitors $1.83 +0.01 (+0.55%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$1.87 +0.04 (+2.19%) As of 07/2/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBIO vs. CDXS, AGEN, SGMO, IRWD, DOMH, ACHV, CRIS, SABS, BOLT, and MTEMShould you be buying Fortress Biotech stock or one of its competitors? The main competitors of Fortress Biotech include Codexis (CDXS), Agenus (AGEN), Sangamo Therapeutics (SGMO), Ironwood Pharmaceuticals (IRWD), Dominari (DOMH), Achieve Life Sciences (ACHV), Curis (CRIS), SAB Biotherapeutics (SABS), Bolt Biotherapeutics (BOLT), and Molecular Templates (MTEM). These companies are all part of the "biotechnology" industry. Fortress Biotech vs. Its Competitors Codexis Agenus Sangamo Therapeutics Ironwood Pharmaceuticals Dominari Achieve Life Sciences Curis SAB Biotherapeutics Bolt Biotherapeutics Molecular Templates Fortress Biotech (NASDAQ:FBIO) and Codexis (NASDAQ:CDXS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership. Is FBIO or CDXS more profitable? Fortress Biotech has a net margin of -71.24% compared to Codexis' net margin of -149.47%. Codexis' return on equity of -118.47% beat Fortress Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Fortress Biotech-71.24% -4,712.53% -27.67% Codexis -149.47%-118.47%-53.37% Which has more risk and volatility, FBIO or CDXS? Fortress Biotech has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Comparatively, Codexis has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500. Which has stronger earnings and valuation, FBIO or CDXS? Fortress Biotech has higher earnings, but lower revenue than Codexis. Codexis is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFortress Biotech$57.67M0.94-$46M-$2.23-0.82Codexis$59.35M3.92-$65.28M-$0.99-2.84 Do analysts rate FBIO or CDXS? Fortress Biotech presently has a consensus target price of $21.00, indicating a potential upside of 1,047.54%. Codexis has a consensus target price of $11.00, indicating a potential upside of 291.46%. Given Fortress Biotech's stronger consensus rating and higher possible upside, equities research analysts plainly believe Fortress Biotech is more favorable than Codexis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fortress Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Codexis 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to FBIO or CDXS? In the previous week, Fortress Biotech had 1 more articles in the media than Codexis. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Codexis. Codexis' average media sentiment score of 1.89 beat Fortress Biotech's score of 0.94 indicating that Codexis is being referred to more favorably in the news media. Company Overall Sentiment Fortress Biotech Positive Codexis Very Positive Do institutionals & insiders have more ownership in FBIO or CDXS? 96.5% of Fortress Biotech shares are owned by institutional investors. Comparatively, 78.5% of Codexis shares are owned by institutional investors. 27.9% of Fortress Biotech shares are owned by insiders. Comparatively, 2.1% of Codexis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryFortress Biotech beats Codexis on 10 of the 16 factors compared between the two stocks. Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBIO vs. The Competition Export to ExcelMetricFortress BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$53.82M$2.88B$5.54B$8.87BDividend YieldN/A2.64%5.39%4.10%P/E Ratio-0.8221.3126.1919.90Price / Sales0.94278.47414.04113.66Price / CashN/A41.4736.1356.90Price / Book-30.507.518.025.38Net Income-$46M-$55.05M$3.15B$248.50M7 Day Performance-1.08%2.07%1.48%2.06%1 Month Performance-0.54%4.84%3.67%4.86%1 Year Performance3.98%5.37%34.68%20.24% Fortress Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBIOFortress Biotech2.5991 of 5 stars$1.83+0.5%$21.00+1,047.5%+9.6%$53.82M$57.67M-0.82170CDXSCodexis3.678 of 5 stars$2.44+2.1%$11.00+350.8%-2.8%$198M$59.35M-2.46250Positive NewsGap UpAGENAgenus4.3048 of 5 stars$4.57-4.0%$14.00+206.3%-61.4%$130.50M$103.46M-0.53440SGMOSangamo Therapeutics2.7246 of 5 stars$0.54+0.1%$4.50+731.3%+67.1%$126.12M$57.80M-1.39480IRWDIronwood Pharmaceuticals4.788 of 5 stars$0.72-1.9%$4.78+566.9%-88.1%$118.27M$351.41M-3.59220Gap UpDOMHDominari0.9616 of 5 stars$5.44-2.0%N/A+163.8%$81.27M$18.15M0.004Positive NewsACHVAchieve Life Sciences1.611 of 5 stars$2.26+1.3%$14.33+534.2%-50.8%$77.35MN/A-1.6920High Trading VolumeCRISCuris2.7972 of 5 stars$2.32+6.9%$17.00+632.8%-72.0%$22.70M$10.91M-0.3760News CoverageGap DownHigh Trading VolumeSABSSAB Biotherapeutics3.6973 of 5 stars$1.76+3.8%$13.25+655.0%-38.8%$15.70M$1.32M0.00140Positive NewsGap UpBOLTBolt Biotherapeutics2.9386 of 5 stars$5.77+2.9%$50.00+766.6%-59.8%$10.75M$7.69M-0.1790Positive NewsHigh Trading VolumeMTEMMolecular TemplatesN/AN/AN/AN/A$1K$23.48M0.00260 Related Companies and Tools Related Companies CDXS Alternatives AGEN Alternatives SGMO Alternatives IRWD Alternatives DOMH Alternatives ACHV Alternatives CRIS Alternatives SABS Alternatives BOLT Alternatives MTEM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBIO) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBIO Stock Alerts